DIAGNOSTIC TESTS TEST KITS

Brand	Owner (click to sort)	Address	Description
BIOSTRAT	BioVantra	P.O. Box 772287 Ocala FL 34477	Diagnostic tests and test kits comprised of biological sample collection and storage containers, DNA probes, reagents and antibodies for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins and other analytes in biological samples for the diagnosis of diseases, the monitoring and prediction of disease incidence and progression, and for determining drug responses;BIO STRAT;Diagnostic reagents for clinical or medical laboratory use;Medical device, namely, a device for use in oncologic diagnosis, prognosis and therapeutic testing; medical device, namely, instruments for quantitative analysis of protein and nucleic acid biomarkers, namely, apparatus for molecular characterization of biological specimens;
CHROMOCOUNT	Seqll, Inc.	Suite 210 317 New Boston Street Woburn MA 01801	Diagnostic tests and test kits, chips, arrays, and analyzers for conducting single molecule sequencing reactions, namely, reactions for the sequencing of DNA and/or RNA for genomic analysis for clinical or medical laboratory purposes; diagnostic tests and test kits, chips, arrays, and analyzers for determination of genomic information by sequencing for clinical or medical laboratory purposes; Preparations for detecting genetic predispositions for medical purposes; Medical diagnostic reagents and assays that test for detection of genetic traits, genetic degeneration, genetic diseases and genetic abnormalities;CHROMO COUNT;Diagnostic tests and test kits, chips, arrays, and analyzers for conducting single molecule sequencing reactions, namely, reactions for the sequencing of DNA and/or RNA for genomic analysis for scientific and research purposes; diagnostic tests and test kits, chips, arrays, and analyzers for determination of genomic information by sequencing for scientific and research purposes; Assays and reagents for use in genetic research; Test kits for conducting RNA and DNA sequencing for laboratory or research use;
HAPLOSEQ	Ludwig Institute for Cancer Research Ltd.	Stadelhoferstrasse 22 Zürich 8001 Switzerland	Diagnostic tests and test kits primarily composed of reagents, enzymes, and nucleotides for determination of genetic information for medical purposes; Reagents, enzymes, and nucleotides for scientific or medical research use; Reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; cell lines for medical purposes; Assays and reagents for use in genetic research and genetic testing; Diagnostic preparations for medical and veterinary use;HAPLO SEQ;genetic testing of animals for diagnostic or treatment purposes; DNA screening for medical purposes; Genetic testing for medical purposes;Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Providing information in the field of plant genetics research resources; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Scientific research consulting in the field of genetics; DNA screening for scientific research purposes; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

A method of pipelining a disease specific diagnostic algorithm on an n-bit data word stored in a memory whereby the n-bit data word is divided into clinical tests describing ranges of normal values. Then, each of the clinical tests of the n-bit data word is read out from memory. Upon receiving a first of the results of the clinical tests, the result is compared with the normal value and the detection algorithm is computed based on the first result. This results in continuation with the next test if positive or terminate if negative. The above-steps are repeated recursively until all of the required test in the diagnostic algorithm are computed to provide the complete diagnosis of a disease.